PapersPMID:22205314
Exploration of the safe upper level of iodine intake in euthyroid Chinese adults: a randomized double-blind trial.
What moved
1 findingHow to read these marks →“In comparison with the placebo group, all iodide-supplemented groups responded with significant increases in median urinary iodine concentrations (P < 0.05) and in thyroid-stimulating hormone concentration (P < 0.05).”
- Study
- RCT
- Duration
- 4 weeks
- Dose studied
- oral iodine supplement, 12 groups, doses 0 to 2000 μg/d
- Population
- Euthyroid Chinese adults; all iodide-supplemented dose groups (doses up to 2000 μg/d) compared with the placebo group
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- euthyroid adults in China
- Participants
- 256
- Comparator
- placebo
- Duration
- 28 days
- Endpoints measured
- 6